Rejuvenate Bio

📍 United States🗓 Founded 2019👥 16 employees💰 Last funded May 2026
Rejuvenate Bio is targeting the core drivers of chronic age-related diseases by unlocking the power of gene expression and epigenetic reprogramming to reverse pre-existing heart disease, metabolic disease, and kidney failure in humans.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2019
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Rejuvenate Bio?
Rejuvenate Bio has 1 investors on record on gritt.io and 1 late-stage investors.
When did Rejuvenate Bio last raise funding?
The most recent investment in Rejuvenate Bio recorded on gritt.io was in May 2026.
When was Rejuvenate Bio founded?
Rejuvenate Bio was founded in 2019.
What industry is Rejuvenate Bio in?
Rejuvenate Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rejuvenate Bio based?
Rejuvenate Bio is headquartered in United States.